Tuan Truong, MD
Plastic and Reconstructive Surgery · Webster, TXNPI 1447451042
Payments from drug & device makers
What this record shows
This record is dominated by other: $14,101 of the $15,729 with a category attached, or 89.6%. Johnson & Johnson accounts for 87.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $13,892 and has fallen 91.4% since, to $1,198 in 2025.
Across 57 payments — averaging $275.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$14K
- AbbVie$691
- Integra Lifesciences Corporation$378
- Mentor Worldwide LLC$142
- Acera Surgical, Inc.$107
- Baxter Healthcare$107
- plus $529 from 13 others
What the payments were for
- Food & beverage$1,62810%
- Other$14,10190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $13,775 |
| AbbVie(2 entities) | 26 | $691 |
| Integra Lifesciences Corporation | 3 | $378 |
| Mentor Worldwide LLC | 5 | $142 |
| Acera Surgical, Inc. | 1 | $107 |
| Baxter Healthcare | 3 | $107 |
| Aroa Biosurgery Incorporated | 2 | $95 |
| Boston Scientific | 2 | $93 |
| Axogen | 2 | $61 |
| Davol Inc. | 1 | $47 |
| TELA Bio, Inc. | 2 | $44 |
| Vertex | 1 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $32 |
| Medtronic | 1 | $27 |
| Urgo Medical North America, LLC | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Kerecis Limited | 2 | $20 |
| Coopersurgical, Inc. | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,729 in reported general payments places this provider in the 85th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $607 |
| Cyclobenzaprine Hcl | 13 | $134 |
| Minocycline Hcl | 17 | $104 |
| Ondansetron Hcl | 16 | $90 |
| Gabapentin | 21 | $62 |
| Tramadol Hcl | 17 | $47 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Webster
- Shitel PatelWebster$44K
- Clayton MoliverWebster$40K
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Alina SholarAustin$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.